It was a pleasure to talk with Dr Ronald Strauss (Cleveland Allergy and Asthma Center; Case Western Reserve University Medical School, Cleveland, OH, USA) around his article exploring the use of intranasal corticosteroids in the prevention and/ or treatment of COVID-19.
- What is known about the major ports of entry for the SARS-CoV-2 virus? (0:19)
- What was the rationale for your study? (0:42)
- Could you tell us a little about the study design and findings? (2:30)
- What are the clinical implications of these findings? (4:26)
- What further data are needed before intranasal corticosteroids can be recommended to prevent or treat COVID-19? (5:04)
Citation: Strauss R, Jawhari N, Attaway AH et al. Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9: P3934-3940.E9.
Disclosures: Ronald Strauss has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Share this Video
Related Videos In COVID-19
Margaret Pisani, Research highlights in COVID-19 from 2022
Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]
Alan Kaplan: IPCRG COVID-19 and Respiratory Q&A – COVID-19 Controversies, Vaccination and Booster Doses
The IPCRG COVID-19 and Respiratory Q&A is providing evidence based COVID and respiratory advice to practising primary care clinicians. Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) answers questions from the Q&A on managing COVID-19, how to address the controversies surrounding the COVID-19 vaccines, and the immunity provided from COVID-19 vaccination and booster doses. […]
Fiona Mosgrove: IPCRG COVID-19 and Respiratory Q&A – a Focus on COVID-19
touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments for COVID-19 and what will happen as we move out of the pandemic. Questions Could you give […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!